PAIA
ACHC icon

Park Avenue Institutional Advisers’s Acadia Healthcare ACHC Stock Holding History

Park Avenue Institutional Advisers’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,550
Closed -$373K – 3
2017
Q1 		$373K Hold
8,550
– – 3.56% 6
2016
Q4 		$283K Hold
8,550
– – 2.26% 7
2016
Q3 		$423K Hold
8,550
– – 3.36% 4
2016
Q2 		$474K Hold
8,550
– – 0.41% 54
2016
Q1 		$471K Buy
+8,550
New +$488K 0.41% 55

Other funds holding ACHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Park Avenue Institutional Advisers's ACHC Position: Q2 2017 in Review

Park Avenue Institutional Advisers sold out of Acadia Healthcare (ACHC) in Q2 2017, closing a stake of 8,550 shares — an estimated $373K sold.

Park Avenue Institutional Advisers first reported a position in ACHC in Q1 2016 and held it in 5 quarters. The position peaked at $474K in Q2 2016. 249 funds tracked by Wall St. Rank hold ACHC as of Q2 2017.

  • Park Avenue Institutional Advisers reported no remaining Acadia Healthcare position as of Q2 2017 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 8,550 Acadia Healthcare shares in Q2 2017, an estimated $373K.
  • Park Avenue Institutional Advisers first reported a position in Acadia Healthcare in Q1 2016 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Acadia Healthcare position peaked at $474K in Q2 2016.
  • 249 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2017.

Based on Park Avenue Institutional Advisers's 13F filing for Q2 2017, filed 14 Aug 2017.